Report overview
Cardiovascular diseases present a wide range of blood disorders (haemostasis) that influences the development cardiovascular co morbidities. Patients exhibiting such symptoms are often prescribed on anti-thrombotic medications to prevent the onset of adverse cardiovascular events arising as a result of the sudden rise in blood coagulation factors. In addition, patients undergoing cardiovascular surgery also present haemostatic disorders along with their existing disease state besides their adjunctive medication or the presence of any coagulation disturbances induced by a cardiopulmonary bypass surgery. POC (Point of care) coagulation testing monitors are available for monitoring preoperative coagulation especially in procedures involving cardiovascular surgeries such as cardiac bypass, angioplasty, etc.
This report contains market size and forecasts of Decentralized/POC Coagulation Testing in Global, including the following market information:
Global Decentralized/POC Coagulation Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Decentralized/POC Coagulation Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Coagulated Plasma Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Decentralized/POC Coagulation Testing include Roche Diagnostics, Abbott Laboratories, Biosite Diagnostic, Medtronic, Trinity Biotech and Polartechnics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Decentralized/POC Coagulation Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Decentralized/POC Coagulation Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Decentralized/POC Coagulation Testing Market Segment Percentages, by Type, 2021 (%)
Anti-Coagulated Plasma Technology
Whole Blood Specimen Testing Kits
Satellite Anticoagulation Therapy
Global Decentralized/POC Coagulation Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Decentralized/POC Coagulation Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Decentralized/POC Coagulation Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Decentralized/POC Coagulation Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decentralized/POC Coagulation Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Decentralized/POC Coagulation Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Abbott Laboratories
Biosite Diagnostic
Medtronic
Trinity Biotech
Polartechnics
